Cargando…

Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study

Despite type I haemochromatosis (HC) is mainly associated with the HFE C282Y/C282Y genotype, a second genotype -C282Y/H63D- has mostly been described in other patients. Its association with HC, apart from any associated co-morbid factors, remains unclear and complex to interpret for physicians. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Saliou, Philippe, Le Gac, Gérald, Mercier, Anne-Yvonne, Chanu, Brigitte, Guéguen, Paul, Mérour, Marie-Christine, Gourlaouen, Isabelle, Autret, Sandrine, Le Maréchal, Cédric, Rouault, Karen, Nousbaum, Jean-Baptiste, Férec, Claude, Scotet, Virginie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855242/
https://www.ncbi.nlm.nih.gov/pubmed/24339903
http://dx.doi.org/10.1371/journal.pone.0081128
_version_ 1782294905261916160
author Saliou, Philippe
Le Gac, Gérald
Mercier, Anne-Yvonne
Chanu, Brigitte
Guéguen, Paul
Mérour, Marie-Christine
Gourlaouen, Isabelle
Autret, Sandrine
Le Maréchal, Cédric
Rouault, Karen
Nousbaum, Jean-Baptiste
Férec, Claude
Scotet, Virginie
author_facet Saliou, Philippe
Le Gac, Gérald
Mercier, Anne-Yvonne
Chanu, Brigitte
Guéguen, Paul
Mérour, Marie-Christine
Gourlaouen, Isabelle
Autret, Sandrine
Le Maréchal, Cédric
Rouault, Karen
Nousbaum, Jean-Baptiste
Férec, Claude
Scotet, Virginie
author_sort Saliou, Philippe
collection PubMed
description Despite type I haemochromatosis (HC) is mainly associated with the HFE C282Y/C282Y genotype, a second genotype -C282Y/H63D- has mostly been described in other patients. Its association with HC, apart from any associated co-morbid factors, remains unclear and complex to interpret for physicians. This study assesses the weight of this genotype and the role of co-morbid factors in the occurrence of iron overload. This prospective study included the C282Y/C282Y (n = 172) and C282Y/H63D (n = 58) patients enrolled in a phlebotomy program between 2004 and 2007 in a blood centre of western Brittany (Brest, France), where HC is frequent. We compared prevalence of these two genotypes, as well as patients’ profile regarding degree of iron overload and prevalence of co-morbid factors. First, we confirmed the obvious deficit of C282Y/H63D compound heterozygotes among patients cared by phlebotomies. This genotype was 3.0 times less frequent than the C282Y/C282Y genotype among those patients (18.9% vs. 56.0%) whereas it was 4.9 times more frequent in the general population (4.3% vs. 0.9%; p<0.0001). Despite a similar level of hyperferritinaemia, the C282Y/H63D patients who came to medical attention had a milder plasma iron overload, reflected by a lower transferrin saturation median (52.0% vs. 84.0%; p<0.0001). They also exhibited more frequently co-morbid factors, as heavy drinking (26.0% vs. 13.9%; p = 0.0454), overweight (66.7% vs. 39.4%; p = 0.0005) or both (21.3% vs. 2.6%; p<0.0001). Ultimately, they required a lower amount of iron removed to reach depletion (2.1 vs. 3.4 g; p<0.0001), clearly reflecting their lower tissue iron. This study confirms that H63D is a discrete genetic susceptibility factor whose expression is most visible in association with other co-factors. It highlights the importance of searching for co-morbidities in these diagnostic situations and of providing lifestyle and dietary advice.
format Online
Article
Text
id pubmed-3855242
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38552422013-12-11 Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study Saliou, Philippe Le Gac, Gérald Mercier, Anne-Yvonne Chanu, Brigitte Guéguen, Paul Mérour, Marie-Christine Gourlaouen, Isabelle Autret, Sandrine Le Maréchal, Cédric Rouault, Karen Nousbaum, Jean-Baptiste Férec, Claude Scotet, Virginie PLoS One Research Article Despite type I haemochromatosis (HC) is mainly associated with the HFE C282Y/C282Y genotype, a second genotype -C282Y/H63D- has mostly been described in other patients. Its association with HC, apart from any associated co-morbid factors, remains unclear and complex to interpret for physicians. This study assesses the weight of this genotype and the role of co-morbid factors in the occurrence of iron overload. This prospective study included the C282Y/C282Y (n = 172) and C282Y/H63D (n = 58) patients enrolled in a phlebotomy program between 2004 and 2007 in a blood centre of western Brittany (Brest, France), where HC is frequent. We compared prevalence of these two genotypes, as well as patients’ profile regarding degree of iron overload and prevalence of co-morbid factors. First, we confirmed the obvious deficit of C282Y/H63D compound heterozygotes among patients cared by phlebotomies. This genotype was 3.0 times less frequent than the C282Y/C282Y genotype among those patients (18.9% vs. 56.0%) whereas it was 4.9 times more frequent in the general population (4.3% vs. 0.9%; p<0.0001). Despite a similar level of hyperferritinaemia, the C282Y/H63D patients who came to medical attention had a milder plasma iron overload, reflected by a lower transferrin saturation median (52.0% vs. 84.0%; p<0.0001). They also exhibited more frequently co-morbid factors, as heavy drinking (26.0% vs. 13.9%; p = 0.0454), overweight (66.7% vs. 39.4%; p = 0.0005) or both (21.3% vs. 2.6%; p<0.0001). Ultimately, they required a lower amount of iron removed to reach depletion (2.1 vs. 3.4 g; p<0.0001), clearly reflecting their lower tissue iron. This study confirms that H63D is a discrete genetic susceptibility factor whose expression is most visible in association with other co-factors. It highlights the importance of searching for co-morbidities in these diagnostic situations and of providing lifestyle and dietary advice. Public Library of Science 2013-12-05 /pmc/articles/PMC3855242/ /pubmed/24339903 http://dx.doi.org/10.1371/journal.pone.0081128 Text en © 2013 Saliou et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Saliou, Philippe
Le Gac, Gérald
Mercier, Anne-Yvonne
Chanu, Brigitte
Guéguen, Paul
Mérour, Marie-Christine
Gourlaouen, Isabelle
Autret, Sandrine
Le Maréchal, Cédric
Rouault, Karen
Nousbaum, Jean-Baptiste
Férec, Claude
Scotet, Virginie
Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study
title Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study
title_full Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study
title_fullStr Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study
title_full_unstemmed Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study
title_short Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study
title_sort evidence for the high importance of co-morbid factors in hfe c282y/h63d patients cared by phlebotomies: results from an observational prospective study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855242/
https://www.ncbi.nlm.nih.gov/pubmed/24339903
http://dx.doi.org/10.1371/journal.pone.0081128
work_keys_str_mv AT saliouphilippe evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy
AT legacgerald evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy
AT mercieranneyvonne evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy
AT chanubrigitte evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy
AT gueguenpaul evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy
AT merourmariechristine evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy
AT gourlaouenisabelle evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy
AT autretsandrine evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy
AT lemarechalcedric evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy
AT rouaultkaren evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy
AT nousbaumjeanbaptiste evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy
AT ferecclaude evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy
AT scotetvirginie evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy